EverSource Wealth Advisors’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17K Buy
171
+54
+46% +$5.44K ﹤0.01% 2565
2026
Q1
$10.3K Buy
117
+93
+388% +$8.01K ﹤0.01% 2895
2025
Q4
$1.88K Buy
24
+11
+85% +$837 ﹤0.01% 3522
2025
Q3
$871 Sell
13
-65
-83% -$4.68K ﹤0.01% 3803
2025
Q2
$7.35K Buy
78
+49
+169% +$5.38K ﹤0.01% 2985
2025
Q1
$3.44K Buy
29
+9
+45% +$1.23K ﹤0.01% 2675
2024
Q4
$2.64K Buy
20
+9
+82% +$1.1K ﹤0.01% 2610
2024
Q3
$1.43K Hold
11
﹤0.01% 2631
2024
Q2
$1.26K Hold
11
﹤0.01% 2685
2024
Q1
$1.17K Sell
11
-36
-77% -$3.63K ﹤0.01% 2535
2023
Q4
$4.92K Buy
+47
New +$4.58K ﹤0.01% 1867
2023
Q2
Sell
-14
Closed -$2.45K 2555
2023
Q1
$2.45K Sell
14
-14
-50% -$2.51K ﹤0.01% 1878
2022
Q4
$4.65K Buy
28
+14
+100% +$2.19K ﹤0.01% 1637
2022
Q3
$2K Buy
+14
New +$2.55K ﹤0.01% 1698

Other funds holding MLAB

EverSource Wealth Advisors's MLAB Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Mesa Laboratories (MLAB) stake by 46% in Q2 2026, buying an estimated $5.44K and bringing the position to 171 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #2565.

EverSource Wealth Advisors first reported a position in MLAB in Q3 2022 and has held it in 14 quarters since. 33 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • EverSource Wealth Advisors held 171 shares of Mesa Laboratories worth $17K as of Q2 2026.
  • EverSource Wealth Advisors bought 54 Mesa Laboratories shares in Q2 2026, an estimated $5.44K.
  • Mesa Laboratories made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2565 holding.
  • EverSource Wealth Advisors first reported a position in Mesa Laboratories in Q3 2022 and has held it in 14 quarters since.
  • 33 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.